Profound Medical Corp. (PROF)

Profound Medical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 20, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	175	225	202	223	234	403
Market Cap Growth	-9.52%	11.58%	-9.56%	-4.57%	-41.98%	199.27%
Enterprise Value	155	206	176	178	163	318
Last Close Price	5.88	7.51	8.49	10.89	11.23	20.56
PS Ratio	12.26	21.10	28.06	33.43	34.05	55.23
PB Ratio	5.45	3.73	6.47	4.30	2.90	4.14
P/TBV Ratio	5.47	3.75	6.57	4.35	3.06	4.35
EV/Sales Ratio	10.87	19.27	24.43	26.58	23.77	43.61
Debt / Equity Ratio	0.15	0.09	0.25	0.16	0.02	0.02
Asset Turnover	0.34	0.19	0.13	0.09	0.07	0.11
Inventory Turnover	0.53	0.57	0.39	0.48	0.62	0.85
Quick Ratio	3.32	9.44	5.26	12.63	16.50	18.99
Current Ratio	4.18	10.52	6.58	14.82	18.56	20.33
Return on Equity (ROE)	-124.49%	-60.70%	-68.06%	-43.23%	-34.50%	-38.71%
Return on Assets (ROA)	-62.44%	-36.19%	-33.05%	-24.47%	-19.79%	-17.51%
Return on Capital (ROIC)	-71.15%	-39.50%	-36.06%	-26.02%	-20.92%	-18.96%
Return on Capital Employed (ROCE)	-130.50%	-51.90%	-76.20%	-49.10%	-36.70%	-18.90%
Earnings Yield	-22.45%	-12.34%	-14.02%	-12.84%	-13.12%	-5.36%
FCF Yield	-21.41%	-10.41%	-11.19%	-11.55%	-9.57%	-5.10%
Buyback Yield / Dilution	-22.70%	-16.91%	-1.69%	-1.79%	-18.33%	-55.83%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q